<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" xml:lang="en" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Eur J Clin Microbiol Infect Dis</journal-id><journal-id journal-id-type="iso-abbrev">Eur J Clin Microbiol Infect Dis</journal-id><journal-id journal-id-type="pmc-domain-id">3814</journal-id><journal-id journal-id-type="pmc-domain">phenaturepg</journal-id><journal-title-group><journal-title>European Journal of Clinical Microbiology &amp; Infectious Diseases</journal-title></journal-title-group><issn pub-type="ppub">0934-9723</issn><issn pub-type="epub">1435-4373</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>Springer Nature - PMC COVID-19 Collection</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC7520378</article-id><article-id pub-id-type="pmcid-ver">PMC7520378.1</article-id><article-id pub-id-type="pmcaid">7520378</article-id><article-id pub-id-type="pmcaiid">7520378</article-id><article-id pub-id-type="pmid">32986153</article-id><article-id pub-id-type="doi">10.1007/s10096-020-04038-9</article-id><article-id pub-id-type="publisher-id">4038</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Children were less frequently infected with SARS-CoV-2 than adults during 2020 COVID-19 pandemic in Warsaw, Poland</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Kuchar</surname><given-names initials="E">Ernest</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Za&#322;&#281;ski</surname><given-names initials="A">Andrzej</given-names></name><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Wronowski</surname><given-names initials="M">Micha&#322;</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Krankowska</surname><given-names initials="D">Dagny</given-names></name><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Podsiad&#322;y</surname><given-names initials="E">Edyta</given-names></name><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Brodaczewska</surname><given-names initials="K">Klaudia</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Lewicka</surname><given-names initials="A">Aneta</given-names></name><xref ref-type="aff" rid="Aff6">6</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Lewicki</surname><given-names initials="S">S&#322;awomir</given-names></name><xref ref-type="aff" rid="Aff7">7</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Kieda</surname><given-names initials="C">Claudine</given-names></name><xref ref-type="aff" rid="Aff5">5</xref><xref ref-type="aff" rid="Aff8">8</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Horban</surname><given-names initials="A">Andrzej</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Kloc</surname><given-names initials="M">Ma&#322;gorzata</given-names></name><xref ref-type="aff" rid="Aff9">9</xref><xref ref-type="aff" rid="Aff10">10</xref><xref ref-type="aff" rid="Aff11">11</xref></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0003-2772-5127</contrib-id><name name-style="western"><surname>Kubiak</surname><given-names initials="JZ">Jacek Z.</given-names></name><address><email>jacek.kubiak@univ-rennes1.fr</email></address><xref ref-type="aff" rid="Aff7">7</xref><xref ref-type="aff" rid="Aff12">12</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.13339.3b</institution-id><institution-id institution-id-type="ISNI">0000000113287408</institution-id><institution>Department of Paediatrics with Clinical Assessment Unit, </institution><institution>Medical University of Warsaw, </institution></institution-wrap>Warsaw, Poland </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="GRID">grid.13339.3b</institution-id><institution-id institution-id-type="ISNI">0000000113287408</institution-id><institution>Department of Infectious Diseases, Tropical Diseases and Hepatology, </institution><institution>Medical University of Warsaw, </institution></institution-wrap>Warsaw, Poland </aff><aff id="Aff3"><label>3</label>Hospital of Infectious Diseases, Warsaw, Poland </aff><aff id="Aff4"><label>4</label>Department of Laboratory Diagnostics and Clinical Immunology of Developmental Age, Public Paediatric Teaching Hospital, Warsaw, Poland </aff><aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="GRID">grid.415641.3</institution-id><institution-id institution-id-type="ISNI">0000 0004 0620 0839</institution-id><institution>Laboratory of Molecular Oncology and Innovative Therapies, </institution><institution>Military Institute of Medicine, </institution></institution-wrap>Szaser&#243;w 128, 01-163 Warsaw, Poland </aff><aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="GRID">grid.419840.0</institution-id><institution-id institution-id-type="ISNI">0000 0001 1371 5636</institution-id><institution>Laboratory of Food and Nutrition Hygiene, </institution><institution>Military Institute of Hygiene and Epidemiology (WIHE), </institution></institution-wrap>Kozielska 4, 01-163 Warsaw, Poland </aff><aff id="Aff7"><label>7</label><institution-wrap><institution-id institution-id-type="GRID">grid.419840.0</institution-id><institution-id institution-id-type="ISNI">0000 0001 1371 5636</institution-id><institution>Department of Regenerative Medicine and Cell Biology, </institution><institution>Military Institute of Hygiene and Epidemiology (WIHE), </institution></institution-wrap>Kozielska 4, Warsaw, Poland </aff><aff id="Aff8"><label>8</label>Centre for Molecular Biophysics, Cell Recognition and Glycobiology, UPR4301-CNRS, rue Charles Sadron, 45071 Orl&#233;ans, France </aff><aff id="Aff9"><label>9</label><institution-wrap><institution-id institution-id-type="GRID">grid.63368.38</institution-id><institution-id institution-id-type="ISNI">0000 0004 0445 0041</institution-id><institution>The Houston Methodist Research Institute, </institution></institution-wrap>Houston, TX USA </aff><aff id="Aff10"><label>10</label><institution-wrap><institution-id institution-id-type="GRID">grid.63368.38</institution-id><institution-id institution-id-type="ISNI">0000 0004 0445 0041</institution-id><institution>Department of Surgery, </institution><institution>The Houston Methodist Hospital, </institution></institution-wrap>Houston, TX USA </aff><aff id="Aff11"><label>11</label><institution-wrap><institution-id institution-id-type="GRID">grid.267308.8</institution-id><institution-id institution-id-type="ISNI">0000 0000 9206 2401</institution-id><institution>Department of Genetics, M.D. Anderson Cancer Center, </institution><institution>The University of Texas, </institution></institution-wrap>Houston, TX USA </aff><aff id="Aff12"><label>12</label><institution-wrap><institution-id institution-id-type="GRID">grid.462478.b</institution-id><institution-id institution-id-type="ISNI">0000 0004 0609 882X</institution-id><institution>UnivRennes, CNRS, UMR 6290, </institution><institution>Institute of Genetics and Development of Rennes (IGDR), Cell Cycle Group, Faculty of Medicine, </institution></institution-wrap>Rennes, 35043 cedex, France </aff></contrib-group><pub-date pub-type="epub"><day>28</day><month>9</month><year>2020</year></pub-date><pub-date pub-type="ppub"><year>2021</year></pub-date><volume>40</volume><issue>3</issue><issue-id pub-id-type="pmc-issue-id">365906</issue-id><fpage>541</fpage><lpage>547</lpage><history><date date-type="received"><day>16</day><month>6</month><year>2020</year></date><date date-type="accepted"><day>10</day><month>9</month><year>2020</year></date></history><pub-history><event event-type="pmc-release"><date><day>28</day><month>09</month><year>2020</year></date></event><event event-type="pmc-live"><date><day>28</day><month>09</month><year>2020</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-04-28 05:25:14.980"><day>28</day><month>04</month><year>2024</year></date></event></pub-history><permissions><copyright-statement>&#169; Springer-Verlag GmbH Germany, part of Springer Nature 2020</copyright-statement><license><license-p>This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="10096_2020_Article_4038.pdf"/><abstract id="Abs1"><p id="Par1">Clinical data suggest that during the current COVID-19 pandemic, children are less prone than adults to SARS-CoV-2 infection. Our purpose was to determine the frequency of SARS-CoV-2 in children vs. adults during the 2020 pandemic in Warsaw, Poland, and to investigate whether RSV and/or influenza A/B infections were associated with SARS-CoV-2 infections. We present results of RT-PCR tests for SARS-CoV-2 performed in Warsaw, Poland. Some of the pediatric subjects were also PCR-tested for RSV, and A and B influenza. We compared the test results from the four groups of symptomatic and asymptomatic subjects: 459 symptomatic pediatric patients (children 0&#8211;18 years old), 1774 symptomatic adults, 445 asymptomatic children, and 239 asymptomatic adults. 3.26% (15/459) of symptomatic pediatric patients were positive for SARS-CoV-2 in contrast to 5.58% (99/1774) of symptomatic adults (<italic toggle="yes">p</italic> = 0.0448). There were no SARS-CoV-2 positive cases in the group of asymptomatic children (0/445) and two positive cases in the group of asymptomatic adults (2/239), i.e., 0.83%. In the group of symptomatic pediatric patients, 17.14% (6/35) (<italic toggle="yes">p</italic> = 0.0002) were positive for RSV, 8.16% (4/49) were positive for influenza A, and 2.04% (1/49), thus 10.20% (5/49) (<italic toggle="yes">p</italic> = 0.0176) for influenza A/B. Children were less prone to SARS-CoV-2 infection than the adults during the COVID-19 pandemic in Warsaw. Higher percentage of symptomatic children was infected with RSV or influenza A/B than with SARS-CoV-2. This suggests a necessity for the testing for all these viruses for an early identification and isolation of SARS-CoV-2-positive patients for an ensuing 2020 autumn return of COVID-19.</p><sec><title>Electronic supplementary material</title><p>The online version of this article (10.1007/s10096-020-04038-9) contains supplementary material, which is available to authorized users.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>COVID-19</kwd><kwd>SARS-CoV-2</kwd><kwd>2020 pandemic</kwd><kwd>Pediatric patients</kwd></kwd-group><funding-group><award-group><funding-source><institution>Polish Ministry of National Defense </institution></funding-source><award-id>&#8220;Ko&#347;ciuszko" # 5508/2017/DA</award-id><principal-award-recipient><name name-style="western"><surname>Kubiak</surname><given-names>Jacek Z.</given-names></name></principal-award-recipient></award-group></funding-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#169; Springer-Verlag GmbH Germany, part of Springer Nature 2021</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p id="Par2">Severe acute respiratory syndrome coronavirus-2 or SARS-CoV-2 emerged in Wuhan in Hubei Province in China in December 2019 and rapidly had propagated all over the world causing the COVID-19 pandemic, declared by WHO in March 11 (WHO Director-General&#8217;s opening remarks at the media briefing on COVID-19-11 March [<xref ref-type="bibr" rid="CR37">37</xref>]; <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19%2D%2D-11-march-2020">https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19%2D%2D-11-march-2020</ext-link>). The pandemic and number of cases are still unfolding in many countries while we report this data. In Poland, the first case was reported on March 4th, 2020. During the first 2 weeks of the epidemic, the whole Masovia area, including the Polish capital, Warsaw, became one of the major infected areas in Poland, with 3581 cases by 1st June 2020.</p><p id="Par3">There is a growing body of evidence from different countries with COVID-19 pandemic that children are less frequently infected with SARS-CoV-2. Children are mostly asymptomatic or experience much milder symptoms than the adults [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR21">21</xref>, <xref ref-type="bibr" rid="CR41">41</xref>], although a low percentage of the infected children developed the pediatric multi-system inflammatory syndrome [<xref ref-type="bibr" rid="CR34">34</xref>]. Severe (2&#8211;3%) or critical illness (0.61%) has been reported in pediatric patients analyzed in two systematic reviews and meta-analysis of data from several countries [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR17">17</xref>]. The purpose of our study was to establish if a lower frequency of infection, and lesser severity in children were also true for the 2020 COVID-19 pandemic in Warsaw, Poland.</p></sec><sec id="Sec2"><title>Material and methods</title><sec id="Sec3"><title>Patients</title><p id="Par4">Analyses were performed on two main groups of patients: children, from 1 month to 18 years old, and adults, over 18 years old. Patients from two Warsaw hospitals were enrolled: the Pediatric Teaching Clinical Hospital of Medical University of Warsaw and the Hospital for Infectious Diseases (Warsaw, Poland). Each of these two groups was divided into two subgroups: symptomatic (separately children and adults) and asymptomatic (separately children and adults). Patients presenting with fever, respiratory tract infection syndromes, gastrointestinal symptoms, dyspnea, cough, chest pain, and seizures were included in the symptomatic groups. Two asymptomatic groups were the following: (1) asymptomatic children who underwent screening for SARS-CoV-2 at the admission for planned hospitalization unrelated to COVID-19, (2) asymptomatic legal guardians of the asymptomatic children and medical staff involved in contact tracing.</p></sec><sec id="Sec4"><title>SARS-CoV-2 analysis</title><p id="Par5">Throat or nasopharynx swabs were obtained from the symptomatic and asymptomatic subjects. Immediately after collection, the swabs were placed in viral preservation medium, transported to laboratory in temperature 2&#8211;8 &#176;C, and stored in such conditions until processing. Total RNA was extracted from 140 &#956;l specimen with manual centrifuge column isolation kit (Viral RNA Isolation Kit, ZJ Bio-Tech C, China) according to manufacturer&#8217;s instruction. Extraction volume of 60 &#956;l was obtained for each sample. A 5 &#956;l aliquot of RNA was used for real-time RT-PCR, which targeted simultaneously 3 genes specific for SARS-CoV-2: gene E, N, and ORF1ab (Liferiver Novel Coronavirus (2019-nCoV) Real Time Multiplex RT-PCR Kit, Shanghai ZJ Bio-Tech C, Shanghai, China). Real-time PCR was performed upon CFX96 &#8482; Real-Time PCR Detection System (Bio-Rad, USA). The specificity of the test is 98.1 %, analytical sensitivity 1 &#215; 10<sup>3</sup> copies/ml. The protocol was performed according manufacturer&#8217;s instruction. Real-time RT-PCR was performed under the following conditions: 45 &#176;C for 10 min and 95 &#176;C for 15 min, followed by 45 cycles of amplification at 95 &#176;C for 15 sec and 60 &#176;C for 1 min. Criteria for judging results: CT value &lt; 43 positive; 43 &#8804; CT value &#8804; 45 suspicious positive and &#8805; 45 negative. The positive should meet for all 3 genes tested. Internal control was added into extraction mixture on isolation stage to monitor the whole process. Positive and negative control was included in each run of amplification.</p></sec><sec id="Sec5"><title>RSV and influenza A/B analysis</title><p id="Par6">Selected samples of pediatric symptomatic patients were also tested for the presence of RSV and Influenza A/B virus with qualitative real-time PCR test Xpert&#174; Xpress Flu/RSV (Cepheid, USA). 35 patients were tested for RSV and 49 patients for influenza A and B. Nasopharyngeal specimen were collected from selected pediatric symptomatic patients. After collection the swab were placed in universal transport medium (UTM, Copan Diagnostics). The samples were tested immediately after collection with qualitative real-time PCR test Xpert&#174; Xpress Flu/RSV (Cepheid, USA) according manufacturer&#8217;s instruction on GeneXpert I apparatus. The volume of 300 &#956;l was transferred to the cartridge. Isolation and amplification stage was done automatically by the instrument. Each test was equipped in internal control which monitored whole process. External positive and negative controls were tested with each new applied lot of Xpert Xpress Flu/RSV. The RT-PCR test targets few genes of examined viruses: genes encoding matrix protein, PB2 and PA for Flu A, genes encoding matrix protein and non-structural protein for fly B, genes encoding nucleocapsid of RSV A and RSV B. Sensitivity of the test is estimated on 99%, specificity on 98%.</p><p id="Par7">Results were presented as the percentage of all patients in the given group.</p></sec><sec id="Sec6"><title>Statistical analysis</title><p id="Par8">The data from the adults and children, as well as RSV positive, and influenza A and B positive cases within the selected samples in the symptomatic children group, were analyzed by chi-square test. The <italic toggle="yes">p</italic> value &lt; 0.05 was considered statistically significant. We also analyzed data using the Fisher test.</p></sec></sec><sec id="Sec7"><title>Results</title><p id="Par9">SARS-CoV-2 RT-PCR tests were performed in two centers in Warsaw, Poland, during 3 months between March and May 2020, which corresponded to the first 3 months of COVID-19 epidemics in Poland. Patients were divided into four groups.<list list-type="order"><list-item><p id="Par10">Symptomatic pediatric patients (<italic toggle="yes">n</italic> = 459),</p></list-item><list-item><p id="Par11">Symptomatic adult patients (<italic toggle="yes">n</italic> = 1774),</p></list-item><list-item><p id="Par12">Asymptomatic children (<italic toggle="yes">n</italic> = 445),</p></list-item><list-item><p id="Par13">Asymptomatic adults (<italic toggle="yes">n</italic> = 239).</p></list-item></list></p><p id="Par14">The age strata in each group are showed in Supplementary Materials <xref rid="MOESM1" ref-type="media">1</xref> section.</p><p id="Par15">The tests showed 3.26% (15/459) positive cases among the symptomatic pediatric patients, 5.58% (99/1774) among the symptomatic adults, none in the asymptomatic children (0/445), and 0.83% (2/239) in the asymptomatic adults.</p><p id="Par16">The statistical analysis performed with the chi-square test has shown significantly (<italic toggle="yes">p</italic> = 0.0448) lower incidence of SARS-CoV-2 infection in the symptomatic pediatric population than in the symptomatic adults. This trend was also observed in the asymptomatic groups, however the result was not statistically significant (<italic toggle="yes">p</italic> = 0.0533) (Fig. <xref rid="Fig1" ref-type="fig">1</xref>). The Fisher test analysis gave similar results (Fig. <xref rid="MOESM1" ref-type="media">1</xref> Suppl. Materials).<fig id="Fig1" position="float" orientation="portrait"><label>Fig. 1</label><caption><p>The statistical analysis by chi-square test of the results obtained in <bold>a</bold> symptomatic patients and <bold>b</bold> asymtomaptic patients</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="MO1" position="float" orientation="portrait" xlink:href="10096_2020_4038_Fig1_HTML.jpg"/></fig></p><p id="Par17">The age of 15 positive pediatric symptomatic patients, uniformly covering the whole period between 0.6 and 14.1 years of age, was as follows: 0.6, 06, 0.8, 1.0, 1.8, 4.2, 5.0, 7.3, 9.8, 10.0, 11.0, 11.3, 13.0, 14.0, and 14.1 years.</p><p id="Par18">The analysis of the symptomatic non-SARS-CoV-2 patients showed that 17.14% (6/35) (<italic toggle="yes">p</italic> = 0.0002) of children were positive for RSV, 8.16% (4/49) for influenza A, and 2.04% (1/49) for influenza B; thus, 10.20% (5/49) (<italic toggle="yes">p</italic> = 0.0176) were positive for A and B influenza together (the same 49 patients were tested for influenza A and B). These data were also analyzed using two statistical tests: chi-square (Fig. <xref rid="Fig2" ref-type="fig">2</xref>) and the Fisher test (Fig. <xref rid="MOESM1" ref-type="media">2</xref> Suppl. Materials). In other words, 17.14% of pediatric patients negative for SARS-CoV-2 were positive for RSV, and 10.20% for influenza A/B. Thus, a statistically significantly higher number of pediatric symptomatic patients were positive for either RSV or influenza A/B than for SARS-CoV-2. There was also a single pediatric case of pertussis (whooping cough) diagnosed based on the clinical symptoms. These data show that during the first three months (March-May 2020) of the COVID-19 pandemic in Warsaw, Poland, significantly less pediatric patients were infected with SARS-CoV-2 than RSV and influenza together. Thus, children were more likely to be infected with RSV or influenza A/B than with SARS-CoV-2.<fig id="Fig2" position="float" orientation="portrait"><label>Fig. 2</label><caption><p>The statistical analysis by chi-square test of the results obtained in <bold>a</bold> SARS-CoV-2 vs. RSV tests, <bold>b</bold> SARS-CoV-2 vs. influenza A/B, and <bold>c</bold> RSV vs. influenza A/B</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="MO2" position="float" orientation="portrait" xlink:href="10096_2020_4038_Fig2_HTML.jpg"/></fig></p></sec><sec id="Sec8"><title>Discussion</title><p id="Par19">Our study showed that children presenting symptoms suggestive of COVID-19 and requiring hospitalization or an emergency assessment, had significantly lower SARS-CoV-2 infection than hospitalized adults. This data are consistent with the previous studies from different countries during the 2020 COVID-19 pandemic. Asymptomatic, mild, and moderate symptoms were observed in more than 90% of all COVID-19 positive children; severe and critical cases were observed in 5.9% of children in comparison to 18.5% in adults [<xref ref-type="bibr" rid="CR9">9</xref>]. Cristiani et al. [<xref ref-type="bibr" rid="CR7">7</xref>] report that among the total number of 44,672 positive cases, the Chinese Centre of Disease Control and Prevention report showed only 416 pediatric cases in 0&#8211;9 years age group (0.9%) with no fatalities and 549 cases in 10&#8211;19 years age group (1.2%) with 1 fatality (0.2%). Brodin [<xref ref-type="bibr" rid="CR3">3</xref>] reports Korean data showing that 6.3% of all positive cases were children under 19 years of age. (reviewed also by [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR21">21</xref>, <xref ref-type="bibr" rid="CR41">41</xref>]).</p><p id="Par20">Interestingly, SARS-CoV-1 infection rate during 2002-2003 epidemic had shown similar characteristics regarding children vs. adults in China, and other countries [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR29">29</xref>, <xref ref-type="bibr" rid="CR30">30</xref>, <xref ref-type="bibr" rid="CR40">40</xref>]. Therefore, it seems that children are more resistant to both SARS-CoV-1 and SARS-CoV-2 infection.</p><p id="Par21">There are several factors that might explain this phenomenon. First of all, children, because the milder symptoms of SARS-CoV-2 infection are tested less frequently than the adults. There may be also an input from the environmental/social factors. Children may be better protected and sheltered against the virus during the pandemic than the adults, and the rate of children infection may be influenced by the quality of the parental care [<xref ref-type="bibr" rid="CR41">41</xref>].</p><p id="Par22">Alternatively, some endogenous factors may play a role. They may include a different age-dependent expression and/or distribution of ACE2 receptor for SARS-CoV-1 and SARS-CoV-2 (suggested by [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR20">20</xref>, <xref ref-type="bibr" rid="CR31">31</xref>, <xref ref-type="bibr" rid="CR33">33</xref>, <xref ref-type="bibr" rid="CR35">35</xref>, <xref ref-type="bibr" rid="CR38">38</xref>, <xref ref-type="bibr" rid="CR39">39</xref>]). Indeed, a lower level of ACE2 expression in the nasal epithelial cells of children, especially the youngest children, was confirmed by a recent study of Bunyavanich [<xref ref-type="bibr" rid="CR4">4</xref>] suggesting that this can be a reason for a lower infectability of children with SARS viruses. Nevertheless, the data about the impact of ACE2 expression pattern are still fragmentary.</p><p id="Par23">One of the reasons for the severity of the COVID-19 is the over-reactivity of the immune response in the lungs, where the alveolar macrophages induce the cytokine storm [<xref ref-type="bibr" rid="CR13">13</xref>]. In children, the immune system is immature [<xref ref-type="bibr" rid="CR13">13</xref>], thus aggressive cytokine response is rarely seen [<xref ref-type="bibr" rid="CR28">28</xref>] resulting in milder COVID-19 symptoms. The severity of COVID-19 in children was recently reviewed by two meta-analyses [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR17">17</xref>]. Even though the reviews had large cohorts (7480, 4857 patients), the severity of illness was described only in 20-34% of all patients (1475 and 1666 respectively). In the review by Liguoro et al. [<xref ref-type="bibr" rid="CR17">17</xref>], 12% of neonates were severely ill. In the second review, neonates were not included in the study. The estimated reported mortality in these two studies was 0.08% and 0.1% of analyzed patients. Higher morbidity and mortality ratios were described by the ptbnet COVID-19 study Group who collected data from 25 European countries during the peak of the pandemic in Europe in April 2020 [<xref ref-type="bibr" rid="CR10">10</xref>]. Out of 582 patients, 8% required ICU admission, and 4% required mechanical ventilation. The case fatality rate was 0.69%, and age younger than 1 month, male sex, signs or symptoms of lower respiratory tract infections at presentation, and the presence of pre-existing medical conditions were associated with ICU admission.</p><p id="Par24">Another plausible explanation might be that the children who attend day-care, kindergarten, and school and are frequently exposed to the respiratory viruses, develop some basal level of the antibodies, which give cross protection against SARS-CoV-2 [<xref ref-type="bibr" rid="CR26">26</xref>].</p><p id="Par25">In the case of newborns, and very young babies, a part of explanation can be that they are protected either by antibodies transferred during pregnancy through the placenta from mother [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR24">24</xref>]. or the compounds, such as the lactoferrin, a globular glycoprotein present in the breast milk that have the antimicrobial and immunomodulatory roles in protecting the newborn from the various infections [<xref ref-type="bibr" rid="CR32">32</xref>], including the necrotizing enterocolitis [<xref ref-type="bibr" rid="CR27">27</xref>] and SARS [<xref ref-type="bibr" rid="CR14">14</xref>].</p><p id="Par26">A plausible hypothesis for a lower number of positive cases among children is that a high percentage of them might have been protected by the cross-immunity conferred by infections with other viruses including human coronaviruses (e.g. [<xref ref-type="bibr" rid="CR3">3</xref>]). Also, the vaccination against other infectious diseases may stimulate the cross-immunity. The young patients were probably better protected because of freshly acquired immune memory [<xref ref-type="bibr" rid="CR20">20</xref>]. Of special interest can be the so-called trained immunity caused by vaccinations with live viruses, such as OPV, anti-measles vaccine, or mycobacteria, including BCG [<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR22">22</xref>]. Moreover, the authors also hypothesized that if SARS-CoV-2 will mutate, and the specific vaccine will be weak or ineffective, the OPV may be the only real solution in the future [<xref ref-type="bibr" rid="CR6">6</xref>]. In this case, again, recent vaccination might give a better protective effect.</p><p id="Par27">Interestingly, the PCR tests of children included in our study showed that, within the first three months of the COVID-19 pandemic in Warsaw, the children had significantly higher risk for RSV or influenza A/B than for SARS-CoV-2 infection. If this bias toward RSV and influenza A/B infection persists for the next seasonal peak of flu, and respiratory infections, the physicians in Masovia area should keep in mind that the common flu/respiratory infections are much more frequent than COVID-19. However taking into account the risk of spreading COVID-19, authorities should perform a routine broad testing for all these viruses. The data from many countries show that an early detection of SARS-CoV-2 infection is one of the most effective strategies of pandemic control.</p><p id="Par28">In addition, our study did not show any case of the coinfection between SARS-CoV-2 and other viruses tested, or between RSV and Influenza A/B. Reina and Due&#241;as [<xref ref-type="bibr" rid="CR25">25</xref>] showed that the RSV and influenza coinfection occurred in 4.8% of the total studied RSV cases. It is possible that the limited number of pediatric patients, which were tested for RSV and Influenza A/B in our study is responsible for this discrepancy. In contrast, some studies have reported the presence of coinfections with SARS-CoV-2 and other respiratory tract pathogens, both in children and adults. In most cases studied, the researchers have reported coinfection with others than SARS-CoV-2 coronaviruses (HKU1, NL63, 229E, OC43), influenza, and parainfluenza viruses, RSV, rhinoviruses-enteroviruses, human methapneumoviruses, adenoviruses, and <italic toggle="yes">Mycoplasma pneumoniae</italic>. Nevertheless, the coinfection rates were low and ranged between 0.1% - 3%, and the studies did not clearly assess whether they influenced the course of infection with SARS-CoV-2 or not. In general, the clinical course was mild, ending with full recovery [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR36">36</xref>].</p><p id="Par29">We want to emphasize some limitations of our study. First, the number of examined patients was not very high. We wanted to present our results as quickly as possible to spread the information included in this article before the onset of the expected autumn/winter wave of the pandemic, and for this reason, we have chosen to describe the results of the first 3 months of the pandemic. It allows to draw conclusions, but further studies should be performed to verify whether the observed percentage of children vs. adults infections is similar during the whole period of the pandemic period without the anti-SARS-CoV-2 vaccination.</p></sec><sec id="Sec9"><title>Conclusions</title><p id="Par30">The results of our study are consistent with the previous data showing that SARS-CoV-2 infection in children occurs less often than in the adults. Routine testing for SARS-CoV-2 is crucial for the control of the pandemic, and discerning between COVID-19 and common seasonal respiratory infections.</p></sec><sec sec-type="supplementary-material"><title>Electronic supplementary material</title><sec id="Sec10"><p>
<supplementary-material content-type="local-data" id="MOESM1" position="float" orientation="portrait"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="10096_2020_4038_MOESM1_ESM.docx" position="float" orientation="portrait"><label>ESM 1</label><caption><p>(DOCX 386 kb)</p></caption></media></supplementary-material>
</p></sec></sec></body><back><fn-group><fn><p><bold>Publisher&#8217;s note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><ack><p>We acknowledge the funding from the Polish Ministry of National Defense &#8220;Ko&#347;ciuszko&#8221; # 5508/2017/DA grant to JZK.</p></ack><notes notes-type="author-contribution"><title>Authors&#8217; contributions</title><p>EK, AL, SL, MK, and JZK designed the study. AZ, MW, and DK performed tests; MK and JZK wrote the manuscript; EK, AZ, MW, DK, EP, KB, AL, SL, CK, AH, and JZK analyzed results; AL and SL performed the statistical analysis; EK, AZ, MW, DK, EP, AL, SL, CK, AH, MK, and JZK edited the manuscript.</p></notes><notes notes-type="funding-information"><title>Funding</title><p>JZK was supported by Polish Ministry of National Defense &#8220;Ko&#347;ciuszko&#8221; # 5508/2017/DA grant while preparing this manuscript.</p></notes><notes notes-type="data-availability"><title>Data availability</title><p>All data and material are freely available.</p></notes><notes notes-type="ethics"><title>Compliance with ethical standards</title><notes id="FPar1" notes-type="COI-statement"><title>Conflict of interest</title><p id="Par31">The authors declare that they have no conflict of interest.</p></notes><notes id="FPar2"><title>Ethical approval</title><p id="Par32">No ethical approval was obtained because this study did not involve a clinical evaluation and did not involve laboratory animals and invasive procedures.</p></notes></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><mixed-citation publication-type="other">Balasubramanian S, Rao NM, Goenka A, Roderick M, Ramanan AV (2020) Coronavirus disease (COVID-19) in children-what we know so far and what we do not? Indian Pediatr 57(5):435&#8211;442<pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s13312-020-1819-5</pub-id><pub-id pub-id-type="pmcid">PMC7240240</pub-id><pub-id pub-id-type="pmid">32273490</pub-id></mixed-citation></ref><ref id="CR2"><label>2.</label><mixed-citation publication-type="other">Blasco ML et al (2020) Co-detection of respiratory pathogens in patients hospitalized with coronavirus viral disease-2019 pneumonia. J Med Virol 92:1799&#8211;1801<pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/jmv.25922</pub-id><pub-id pub-id-type="pmid">32320082</pub-id></mixed-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brodin</surname><given-names>P</given-names></name></person-group><article-title>(2020). Why is COVID-19 so mild in children?</article-title><source>Acta Paediatr.</source><year>2020</year><volume>109</volume><issue>6</issue><fpage>1082</fpage><lpage>1083</lpage><pub-id pub-id-type="doi">10.1111/apa.15271</pub-id><pub-id pub-id-type="pmid">32212348</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><mixed-citation publication-type="other">Bunyavanich S (2020) Nasal gene expression of angiotensin-converting enzyme 2 in children and adults. JAMA 323(23):2427&#8211;2429. 10.1001/jama.2020.8707<pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jama.2020.8707</pub-id><pub-id pub-id-type="pmcid">PMC7240631</pub-id><pub-id pub-id-type="pmid">32432657</pub-id></mixed-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cao</surname><given-names>L</given-names></name><name name-style="western"><surname>Wang</surname><given-names>TY</given-names></name><name name-style="western"><surname>Chen</surname><given-names>HZ</given-names></name><name name-style="western"><surname>Qian</surname><given-names>Y</given-names></name><name name-style="western"><surname>Chen</surname><given-names>BW</given-names></name><name name-style="western"><surname>Fang</surname><given-names>P</given-names></name><name name-style="western"><surname>Sun</surname><given-names>YX</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>RN</given-names></name><name name-style="western"><surname>Deng</surname><given-names>J</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>LQ</given-names></name><name name-style="western"><surname>Mi</surname><given-names>J</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>T</given-names></name></person-group><article-title>[A preliminary investigation on the serological and epidemiological characteristics of severe acute respiratory syndrome in children]. [Article in Chinese]</article-title><source>Zhonghua Er Ke Za Zhi</source><year>2004</year><volume>42</volume><issue>11</issue><fpage>840</fpage><lpage>844</lpage><pub-id pub-id-type="pmid">15631713</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chumakov</surname><given-names>K</given-names></name><name name-style="western"><surname>Benn</surname><given-names>CB</given-names></name><name name-style="western"><surname>Aaby</surname><given-names>P</given-names></name><name name-style="western"><surname>Kottilil</surname><given-names>S</given-names></name><name name-style="western"><surname>Gallo</surname><given-names>R</given-names></name></person-group><article-title>Can existing live vaccines prevent COVID-19?</article-title><source>Science</source><year>2020</year><volume>368</volume><issue>6496</issue><fpage>1187</fpage><lpage>1188</lpage><pub-id pub-id-type="doi">10.1126/science.abc4262</pub-id><pub-id pub-id-type="pmid">32527819</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cristiani</surname><given-names>L</given-names></name><name name-style="western"><surname>Mancino</surname><given-names>E</given-names></name><name name-style="western"><surname>Matera</surname><given-names>L</given-names></name><name name-style="western"><surname>Nenna</surname><given-names>R</given-names></name><name name-style="western"><surname>Pierangeli</surname><given-names>A</given-names></name><name name-style="western"><surname>Scagnolari</surname><given-names>C</given-names></name><name name-style="western"><surname>Midulla</surname><given-names>F</given-names></name></person-group><article-title>Will children reveal their secret? The coronavirus dilemma</article-title><source>Eur Respir J</source><year>2020</year><volume>2020</volume><fpage>2000749</fpage><pub-id pub-id-type="doi">10.1183/13993003.00749-2020</pub-id><pub-id pub-id-type="pmcid">PMC7113798</pub-id><pub-id pub-id-type="pmid">32241833</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><mixed-citation publication-type="other">Dhir SK, Kumar J, Meena J, Kumar P (2020) Clinical features and outcome of SARS-CoV-2 infection in neonates: a systematic review. J Trop Pediatr 1&#8211;14. 10.1093/tropej/fmaa059<pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/tropej/fmaa059</pub-id><pub-id pub-id-type="pmcid">PMC7499746</pub-id><pub-id pub-id-type="pmid">32856065</pub-id></mixed-citation></ref><ref id="CR9"><label>9.</label><mixed-citation publication-type="other">Dong Y, Mo X, Hu Y, et al (2020) Epidemiological characteristics of 2143 pediatric patients with 2019 coronavirus disease in China. Pediatrics e20200702. 10.1542/peds.2020-0702</mixed-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>G&#246;tzinger</surname><given-names>F</given-names></name><name name-style="western"><surname>Santiago-Garc&#237;a</surname><given-names>B</given-names></name><name name-style="western"><surname>Noguera-Juli&#225;n</surname><given-names>A</given-names></name><name name-style="western"><surname>Lanaspa</surname><given-names>M</given-names></name><name name-style="western"><surname>Lancella</surname><given-names>L</given-names></name><name name-style="western"><surname>Cal&#242; Carducci</surname><given-names>FI</given-names></name><name name-style="western"><surname>Gabrovska</surname><given-names>N</given-names></name><name name-style="western"><surname>Velizarova</surname><given-names>S</given-names></name><name name-style="western"><surname>Prunk</surname><given-names>P</given-names></name><name name-style="western"><surname>Osterman</surname><given-names>V</given-names></name><name name-style="western"><surname>Krivec</surname><given-names>U</given-names></name><name name-style="western"><surname>Lo Vecchio</surname><given-names>A</given-names></name><name name-style="western"><surname>Shingadia</surname><given-names>D</given-names></name><name name-style="western"><surname>Soriano-Arandes</surname><given-names>A</given-names></name><name name-style="western"><surname>Melendo</surname><given-names>S</given-names></name><name name-style="western"><surname>Lanari</surname><given-names>M</given-names></name><name name-style="western"><surname>Pierantoni</surname><given-names>L</given-names></name><name name-style="western"><surname>Wagner</surname><given-names>N</given-names></name><name name-style="western"><surname>L&#8217;Huillier</surname><given-names>AG</given-names></name><name name-style="western"><surname>Heininger</surname><given-names>U</given-names></name><name name-style="western"><surname>Ritz</surname><given-names>N</given-names></name><name name-style="western"><surname>Bandi</surname><given-names>S</given-names></name><name name-style="western"><surname>Krajcar</surname><given-names>N</given-names></name><name name-style="western"><surname>Rogli&#263;</surname><given-names>S</given-names></name><name name-style="western"><surname>Santos</surname><given-names>M</given-names></name><name name-style="western"><surname>Christiaens</surname><given-names>C</given-names></name><name name-style="western"><surname>Creuven</surname><given-names>M</given-names></name><name name-style="western"><surname>Buonsenso</surname><given-names>D</given-names></name><name name-style="western"><surname>Welch</surname><given-names>SB</given-names></name><name name-style="western"><surname>Bogyi</surname><given-names>M</given-names></name><name name-style="western"><surname>Brinkmann</surname><given-names>F</given-names></name><name name-style="western"><surname>Tebruegge</surname><given-names>M</given-names></name><collab>ptbnet COVID-19 Study Group</collab></person-group><article-title>COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort study</article-title><source>Lancet Child Adolesc Health</source><year>2020</year><volume>4</volume><issue>9</issue><fpage>653</fpage><lpage>661</lpage><pub-id pub-id-type="doi">10.1016/S2352-4642(20)30177-2</pub-id><pub-id pub-id-type="pmid">32593339</pub-id><pub-id pub-id-type="pmcid">PMC7316447</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jackson</surname><given-names>KM</given-names></name><name name-style="western"><surname>Nazar</surname><given-names>AM</given-names></name></person-group><article-title>Breastfeeding, the immune response, and long-term health</article-title><source>J Am Osteopath Assoc</source><year>2006</year><volume>106</volume><fpage>203</fpage><lpage>207</lpage><pub-id pub-id-type="pmid">16627775</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><mixed-citation publication-type="other">Jiatong S, Lanqin L, Wenjun L (2020) COVID-19 epidemic: disease characteristics in children. J Med Virol 92(7):747&#8211;754. 10.1002/jmv.25807<pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/jmv.25807</pub-id><pub-id pub-id-type="pmcid">PMC7228385</pub-id><pub-id pub-id-type="pmid">32232980</pub-id></mixed-citation></ref><ref id="CR13"><label>13.</label><mixed-citation publication-type="other">Kloc M, Ghobrial RM, Kuchar E, Lewicki S, Kubiak JZ (2020) Development of child immunity in the context of COVID-19 pandemic. Clin Immunol 217:108510. 10.1016/j.clim.2020.108510<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.clim.2020.108510</pub-id><pub-id pub-id-type="pmcid">PMC7293525</pub-id><pub-id pub-id-type="pmid">32544611</pub-id></mixed-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lang</surname><given-names>J</given-names></name><name name-style="western"><surname>Yang</surname><given-names>N</given-names></name><name name-style="western"><surname>Deng</surname><given-names>J</given-names></name><name name-style="western"><surname>Liu</surname><given-names>K</given-names></name><name name-style="western"><surname>Yang</surname><given-names>P</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>G</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>C</given-names></name></person-group><article-title>Inhibition of SARS pseudovirus cell entry by lactoferrin binding to heparan sulfate proteoglycans</article-title><source>PLoS One</source><year>2011</year><volume>6</volume><issue>8</issue><fpage>e23710</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0023710</pub-id><pub-id pub-id-type="pmid">21887302</pub-id><pub-id pub-id-type="pmcid">PMC3161750</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>P</given-names></name><name name-style="western"><surname>Hu</surname><given-names>YL</given-names></name><name name-style="western"><surname>Chen</surname><given-names>PY</given-names></name><etal/></person-group><article-title>Are children less susceptible to COVID-19?</article-title><source>J Microbiol Immunol Infect</source><year>2020</year><volume>S1684-1182</volume><issue>20</issue><fpage>30039</fpage><lpage>30036</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jmii.2020.02.011</pub-id><pub-id pub-id-type="pmcid">PMC7102573</pub-id><pub-id pub-id-type="pmid">32147409</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>W</given-names></name><name name-style="western"><surname>Moore</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Vasilieva</surname><given-names>N</given-names></name><name name-style="western"><surname>Sui</surname><given-names>J</given-names></name><name name-style="western"><surname>Wong</surname><given-names>SK</given-names></name><name name-style="western"><surname>Berne</surname><given-names>MA</given-names></name><name name-style="western"><surname>Somasundaran</surname><given-names>M</given-names></name><name name-style="western"><surname>Sullivan</surname><given-names>JL</given-names></name><name name-style="western"><surname>Luzuriaga</surname><given-names>K</given-names></name><name name-style="western"><surname>Greenough</surname><given-names>TC</given-names></name><etal/></person-group><article-title>Angiotensin-converting enzyme 2 is a functional receptor for the sars coronavirus</article-title><source>Nature</source><year>2003</year><volume>426</volume><fpage>450</fpage><lpage>454</lpage><pub-id pub-id-type="doi">10.1038/nature02145</pub-id><pub-id pub-id-type="pmid">14647384</pub-id><pub-id pub-id-type="pmcid">PMC7095016</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liguoro</surname><given-names>I</given-names></name><name name-style="western"><surname>Pilotto</surname><given-names>C</given-names></name><name name-style="western"><surname>Bonanni</surname><given-names>M</given-names></name><name name-style="western"><surname>Ferrari</surname><given-names>ME</given-names></name><name name-style="western"><surname>Pusiol</surname><given-names>A</given-names></name><name name-style="western"><surname>Nocerino</surname><given-names>A</given-names></name><name name-style="western"><surname>Vidal</surname><given-names>E</given-names></name><name name-style="western"><surname>Cogo</surname><given-names>P</given-names></name></person-group><article-title>SARS-COV-2 infection in children and newborns: a systematic review</article-title><source>Eur J Pediatr.</source><year>2020</year><volume>179</volume><issue>7</issue><fpage>1029</fpage><lpage>1046</lpage><pub-id pub-id-type="doi">10.1007/s00431-020-03684-7</pub-id><pub-id pub-id-type="pmid">32424745</pub-id><pub-id pub-id-type="pmcid">PMC7234446</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lovren</surname><given-names>F</given-names></name><name name-style="western"><surname>Pan</surname><given-names>Y</given-names></name><name name-style="western"><surname>Quan</surname><given-names>A</given-names></name><name name-style="western"><surname>Teoh</surname><given-names>H</given-names></name><name name-style="western"><surname>Wang</surname><given-names>G</given-names></name><name name-style="western"><surname>Shukla</surname><given-names>PC</given-names></name><name name-style="western"><surname>Levitt</surname><given-names>KS</given-names></name><name name-style="western"><surname>Oudit</surname><given-names>GY</given-names></name><name name-style="western"><surname>Al-Omran</surname><given-names>M</given-names></name><name name-style="western"><surname>Stewart</surname><given-names>DJ</given-names></name><etal/></person-group><article-title>Angiotensin converting enzyme-2 confers endothelial protection and attenuates atherosclerosis</article-title><source>Am J Physiol Heart Circ Physiol</source><year>2008</year><volume>295</volume><fpage>H1377</fpage><lpage>H1384</lpage><pub-id pub-id-type="doi">10.1152/ajpheart.00331.2008</pub-id><pub-id pub-id-type="pmid">18660448</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Marraro</surname><given-names>GA</given-names></name><name name-style="western"><surname>Spada</surname><given-names>C</given-names></name></person-group><article-title>Consideration of the respiratory support strategy of severe acute respiratory failure caused by SARS-CoV-2 infection in children</article-title><source>Zhongguo Dang Dai Er Ke Za Zhi.</source><year>2020</year><volume>22</volume><issue>3</issue><fpage>183</fpage><lpage>194</lpage><pub-id pub-id-type="pmid">32204751</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.7499/j.issn.1008-8830.2020.03.002</pub-id><pub-id pub-id-type="pmcid">PMC7389599</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><mixed-citation publication-type="other">Miri SM, Noorbakhsh F, Mohebbi SR, Ghaemi A (2020) Higher prevalence of asymptomatic or mild COVID-19 in children, claims and clues. J Med Virol 1&#8211;3. 10.1002/jmv.26069.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/jmv.26069</pub-id><pub-id pub-id-type="pmcid">PMC7283682</pub-id><pub-id pub-id-type="pmid">32470174</pub-id></mixed-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Morand</surname><given-names>A</given-names></name><name name-style="western"><surname>Fabre</surname><given-names>A</given-names></name><name name-style="western"><surname>Minodier</surname><given-names>P</given-names></name><name name-style="western"><surname>Boutin</surname><given-names>A</given-names></name><name name-style="western"><surname>Vanel</surname><given-names>N</given-names></name><name name-style="western"><surname>Bosdure</surname><given-names>E</given-names></name><name name-style="western"><surname>Fournier</surname><given-names>PE</given-names></name></person-group><article-title>COVID-19 virus and children: what do we know?</article-title><source>Arch Pediatr.</source><year>2020</year><volume>27</volume><issue>3</issue><fpage>117</fpage><lpage>118</lpage><pub-id pub-id-type="doi">10.1016/j.arcped.2020.03.001</pub-id><pub-id pub-id-type="pmid">32253003</pub-id><pub-id pub-id-type="pmcid">PMC7269707</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Netea</surname><given-names>MG</given-names></name><name name-style="western"><surname>Giamarellos-Bourboulis</surname><given-names>EJ</given-names></name><name name-style="western"><surname>Dom&#237;nguez-Andr&#233;s</surname><given-names>J</given-names></name><name name-style="western"><surname>Curtis</surname><given-names>N</given-names></name><name name-style="western"><surname>van Crevel</surname><given-names>R</given-names></name><name name-style="western"><surname>van de Veerdonk</surname><given-names>FL</given-names></name><name name-style="western"><surname>Bonten</surname><given-names>M</given-names></name></person-group><article-title>Trained immunity: a tool for reducing susceptibility to and the severity of SARS-CoV-2 infection</article-title><source>Cell</source><year>2020</year><volume>181</volume><issue>5</issue><fpage>969</fpage><lpage>977</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2020.04.042</pub-id><pub-id pub-id-type="pmid">32437659</pub-id><pub-id pub-id-type="pmcid">PMC7196902</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><mixed-citation publication-type="other">Nowak MD, Sordillo EM, Gitman MR, Paniz Mondolfi AE (2020) Co-infection in SARS-CoV-2 infected Patients: Where are influenza virus and rhinovirus/enterovirus? J Med Virol 92:1699&#8211;1700. 10.1002/jmv.25953<pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/jmv.25953</pub-id><pub-id pub-id-type="pmcid">PMC7267652</pub-id><pub-id pub-id-type="pmid">32352574</pub-id></mixed-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Palmeira</surname><given-names>P</given-names></name><name name-style="western"><surname>Quinello</surname><given-names>C</given-names></name><name name-style="western"><surname>L&#250;cia Silveira-Lessa</surname><given-names>A</given-names></name><name name-style="western"><surname>Zago</surname><given-names>A</given-names></name><name name-style="western"><surname>Carneiro-Sampaio</surname><given-names>M</given-names></name></person-group><article-title>IgG placental transfer in healthy and pathological Pregnancies</article-title><source>Clin Dev Immunol</source><year>2012</year><volume>2012</volume><fpage>985646</fpage><pub-id pub-id-type="doi">10.1155/2012/985646</pub-id><pub-id pub-id-type="pmid">22235228</pub-id><pub-id pub-id-type="pmcid">PMC3251916</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Reina</surname><given-names>J</given-names></name><name name-style="western"><surname>Due&#241;as</surname><given-names>J</given-names></name></person-group><article-title>[Respiratory co-infections between influenza viruses and respiratory syncytial virus (2014-2017)] [Article in Spanish]</article-title><source>An Pediatr (Barc).</source><year>2019</year><volume>90</volume><issue>2</issue><fpage>118</fpage><lpage>119</lpage><pub-id pub-id-type="doi">10.1016/j.anpedi.2018.02.011</pub-id><pub-id pub-id-type="pmid">29625806</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schuez-Havupalo</surname><given-names>L</given-names></name><name name-style="western"><surname>Toivonen</surname><given-names>L</given-names></name><name name-style="western"><surname>Karppinen</surname><given-names>S</given-names></name><name name-style="western"><surname>Kaljonen</surname><given-names>A</given-names></name><name name-style="western"><surname>Peltola</surname><given-names>V</given-names></name></person-group><article-title>Daycare attendance and respiratory tract infections: a prospective birth cohort study</article-title><source>BMJ Open</source><year>2020</year><volume>7</volume><issue>9</issue><fpage>e014635</fpage><pub-id pub-id-type="doi">10.1136/bmjopen-2016-014635</pub-id><pub-id pub-id-type="pmcid">PMC5588939</pub-id><pub-id pub-id-type="pmid">28877939</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sherman</surname><given-names>MP</given-names></name></person-group><article-title>Lactoferrin and necrotizing enterocolitis</article-title><source>Clin Perinatol.</source><year>2013</year><volume>40</volume><issue>1</issue><fpage>79</fpage><lpage>91</lpage><pub-id pub-id-type="doi">10.1016/j.clp.2012.12.006</pub-id><pub-id pub-id-type="pmid">23415265</pub-id><pub-id pub-id-type="pmcid">PMC3579561</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Simon</surname><given-names>AK</given-names></name><etal/></person-group><article-title>Evolution of the immune system in humans from infancy to old age</article-title><source>Proc Biol Sci</source><year>2015</year><volume>282</volume><issue>1821</issue><fpage>20143085</fpage><pub-id pub-id-type="doi">10.1098/rspb.2014.3085</pub-id><pub-id pub-id-type="pmid">26702035</pub-id><pub-id pub-id-type="pmcid">PMC4707740</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>S&#248;rensen</surname><given-names>MD</given-names></name><name name-style="western"><surname>S&#248;rensen</surname><given-names>B</given-names></name><name name-style="western"><surname>Gonzalez-Dosal</surname><given-names>R</given-names></name><name name-style="western"><surname>Melchjorsen</surname><given-names>CJ</given-names></name><name name-style="western"><surname>Weibel</surname><given-names>J</given-names></name><name name-style="western"><surname>Wang</surname><given-names>J</given-names></name><name name-style="western"><surname>Jun</surname><given-names>CW</given-names></name><name name-style="western"><surname>Huanming</surname><given-names>Y</given-names></name><name name-style="western"><surname>Kristensen</surname><given-names>P</given-names></name></person-group><article-title>Severe acute respiratory syndrome (SARS): development of diagnostics and antivirals</article-title><source>Ann N Y Acad Sci.</source><year>2006</year><volume>1067</volume><fpage>500</fpage><lpage>505</lpage><pub-id pub-id-type="doi">10.1196/annals.1354.072</pub-id><pub-id pub-id-type="pmid">16804033</pub-id><pub-id pub-id-type="pmcid">PMC7167626</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stockman</surname><given-names>LJ</given-names></name><name name-style="western"><surname>Massoudi</surname><given-names>MS</given-names></name><name name-style="western"><surname>Helfand</surname><given-names>R</given-names></name><name name-style="western"><surname>Erdman</surname><given-names>D</given-names></name><name name-style="western"><surname>Siwek</surname><given-names>AM</given-names></name><name name-style="western"><surname>Anderson</surname><given-names>LJ</given-names></name><name name-style="western"><surname>Parashar</surname><given-names>UD</given-names></name></person-group><article-title>Severe acute respiratory syndrome in children</article-title><source>Pediatr Infect Dis J</source><year>2007</year><volume>26</volume><issue>1</issue><fpage>68</fpage><lpage>74</lpage><pub-id pub-id-type="doi">10.1097/01.inf.0000247136.28950.41</pub-id><pub-id pub-id-type="pmid">17195709</pub-id></element-citation></ref><ref id="CR31"><label>31.</label><mixed-citation publication-type="other">Tai W, He L, Zhang X, Pu J, Voronin D, Jiang S, Zhou Y, Du L (2020) Characterization of the receptor-binding domain (rbd) of 2019 novel coronavirus: implication for development of rbd protein as a viral attachment inhibitor and vaccine. Cell Mol Immunol 17:613&#8211;620. 10.1038/s41423-020-0400-4<pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41423-020-0400-4</pub-id><pub-id pub-id-type="pmcid">PMC7091888</pub-id><pub-id pub-id-type="pmid">32203189</pub-id></mixed-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Telang</surname><given-names>S</given-names></name></person-group><article-title>Lactoferrin: a critical player in neonatal host defense</article-title><source>Nutrients</source><year>2018</year><volume>10</volume><issue>9</issue><fpage>1228</fpage><pub-id pub-id-type="doi">10.3390/nu10091228</pub-id><pub-id pub-id-type="pmcid">PMC6165050</pub-id><pub-id pub-id-type="pmid">30181493</pub-id></element-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tipnis</surname><given-names>SR</given-names></name><name name-style="western"><surname>Hooper</surname><given-names>NM</given-names></name><name name-style="western"><surname>Hyde</surname><given-names>R</given-names></name><name name-style="western"><surname>Karran</surname><given-names>E</given-names></name><name name-style="western"><surname>Christie</surname><given-names>G</given-names></name><name name-style="western"><surname>Turner</surname><given-names>AJ</given-names></name></person-group><article-title>A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase</article-title><source>J Biol Chem</source><year>2000</year><volume>275</volume><fpage>33238</fpage><lpage>33243</lpage><pub-id pub-id-type="doi">10.1074/jbc.M002615200</pub-id><pub-id pub-id-type="pmid">10924499</pub-id></element-citation></ref><ref id="CR34"><label>34.</label><mixed-citation publication-type="other">Viner RM, Whittaker E (2020) Kawasaki-like disease: emerging complication during the COVID-19 pandemic. Lancet 395(10239):1741&#8211;1743. 10.1016/S0140-6736(20)31129-6<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S0140-6736(20)31129-6</pub-id><pub-id pub-id-type="pmcid">PMC7220168</pub-id><pub-id pub-id-type="pmid">32410759</pub-id></mixed-citation></ref><ref id="CR35"><label>35.</label><mixed-citation publication-type="other">Walls AC, Park YJ, Tortorici MA, Wall A, McGuire AT, Veesler D (2020) Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell 180:281&#8211;292. 10.1016/j.cell.2020.02.05<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cell.2020.02.058</pub-id><pub-id pub-id-type="pmcid">PMC7102599</pub-id><pub-id pub-id-type="pmid">32155444</pub-id></mixed-citation></ref><ref id="CR36"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wee</surname><given-names>LE</given-names></name><etal/></person-group><article-title>Community-acquired viral respiratory infections amongst hospitalized inpatients during a COVID-19 outbreak in Singapore: co-infection and clinical outcomes</article-title><source>J Clin Virol</source><year>2020</year><volume>128</volume><fpage>104436</fpage><pub-id pub-id-type="doi">10.1016/j.jcv.2020.104436</pub-id><pub-id pub-id-type="pmid">32447256</pub-id><pub-id pub-id-type="pmcid">PMC7235565</pub-id></element-citation></ref><ref id="CR37"><label>37.</label><mixed-citation publication-type="other">WHO Director-General&#8217;s opening remarks at the media briefing on COVID-19-11 March 2020. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19%2D%2D-11-march-2020">https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19%2D%2D-11-march-2020</ext-link></mixed-citation></ref><ref id="CR38"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wysocki</surname><given-names>J</given-names></name><name name-style="western"><surname>Ye</surname><given-names>M</given-names></name><name name-style="western"><surname>Rodriguez</surname><given-names>E</given-names></name><name name-style="western"><surname>Gonzalez-Pacheco</surname><given-names>FR</given-names></name><name name-style="western"><surname>Barrios</surname><given-names>C</given-names></name><name name-style="western"><surname>Evora</surname><given-names>K</given-names></name><name name-style="western"><surname>Schuster</surname><given-names>M</given-names></name><name name-style="western"><surname>Loibner</surname><given-names>H</given-names></name><name name-style="western"><surname>Brosnihan</surname><given-names>KB</given-names></name><name name-style="western"><surname>Ferrario</surname><given-names>CM</given-names></name><etal/></person-group><article-title>Targeting the degradation of angiotensin ii with recombinant angiotensin-converting enzyme 2: prevention of angiotensin ii-dependent hypertension</article-title><source>Hypertension</source><year>2010</year><volume>55</volume><fpage>90</fpage><lpage>98</lpage><pub-id pub-id-type="doi">10.1161/HYPERTENSIONAHA.109.138420</pub-id><pub-id pub-id-type="pmid">19948988</pub-id><pub-id pub-id-type="pmcid">PMC2827767</pub-id></element-citation></ref><ref id="CR39"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xu</surname><given-names>H</given-names></name><name name-style="western"><surname>Zhong</surname><given-names>L</given-names></name><name name-style="western"><surname>Deng</surname><given-names>J</given-names></name><name name-style="western"><surname>Peng</surname><given-names>J</given-names></name><name name-style="western"><surname>Dan</surname><given-names>H</given-names></name><name name-style="western"><surname>Zeng</surname><given-names>X</given-names></name><name name-style="western"><surname>Li</surname><given-names>T</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Q</given-names></name></person-group><article-title>High expression of ace2 receptor of 2019-ncov on the epithelial cells of oral mucosa</article-title><source>Int J Oral Sci</source><year>2020</year><volume>12</volume><fpage>8</fpage><pub-id pub-id-type="doi">10.1038/s41368-020-0074-x</pub-id><pub-id pub-id-type="pmid">32094336</pub-id><pub-id pub-id-type="pmcid">PMC7039956</pub-id></element-citation></ref><ref id="CR40"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhao</surname><given-names>LQ</given-names></name><name name-style="western"><surname>Qian</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>RN</given-names></name><name name-style="western"><surname>Deng</surname><given-names>J</given-names></name><name name-style="western"><surname>Wang</surname><given-names>F</given-names></name><name name-style="western"><surname>Chen</surname><given-names>HZ</given-names></name><name name-style="western"><surname>Cao</surname><given-names>L</given-names></name><name name-style="western"><surname>Wang</surname><given-names>TY</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>T</given-names></name></person-group><article-title>[Serological analysis of SARS coronavirus in children diagnosed clinically as severe acute respiratory syndrome cases during SARS epidemic in Beijing]. [Article in Chinese]</article-title><source>Zhonghua Er Ke Za Zhi</source><year>2006</year><volume>44</volume><issue>4</issue><fpage>262</fpage><lpage>266</lpage><pub-id pub-id-type="pmid">16780645</pub-id></element-citation></ref><ref id="CR41"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zimmermann</surname><given-names>P</given-names></name><name name-style="western"><surname>Curtis</surname><given-names>N</given-names></name></person-group><article-title>Coronavirus infections in children including COVID-19. An overview of the epidemiology, clinical features, diagnosis, treatment and prevention options in children</article-title><source>Pediatr Infect Dis J</source><year>2020</year><volume>39</volume><issue>5</issue><fpage>355</fpage><lpage>368</lpage><pub-id pub-id-type="doi">10.1097/INF.0000000000002660</pub-id><pub-id pub-id-type="pmid">32310621</pub-id><pub-id pub-id-type="pmcid">PMC7158880</pub-id></element-citation></ref></ref-list></back></article></pmc-articleset>